Northrop Grumman Jumps 7% as Record Backlog Fuels Higher 2026 Outlook

Northrop Grumman (NOC) just gave defense investors something they haven't had much of lately: a clean beat and a higher forecast. Shares jumped about 7% on Tuesday after the company raised its 2026 earnings outlook and reported a record backlog.

The stock had been drifting. It touched a one-year low near $482 on October 1, so Tuesday's move, from a $510.65 close to roughly $545 at its peak, was as much relief as celebration.

Here's the quarter. Adjusted earnings came in at $7.89 a share against Wall Street's roughly $7.18, per MarketBeat's rundown of the results. Sales rose 6.7% to $11.12 billion, essentially in line with the $11.14 billion forecast.

Management then lifted full-year earnings guidance to $29.35-$29.75 a share, up from $28.60-$29.10, as The FINANCIAL reported, citing the Wall Street Journal. Sales guidance stayed put at $43.75-$44.25 billion, so the raise is about profit, not volume.

The number that matters most is backlog. It hit a record $109.6 billion, helped by $16.4 billion in new awards during the quarter, including $2 billion for the Sentinel ICBM program and $1.4 billion for Virginia-class submarines.

That works out to a book-to-bill ratio of about 1.5, according to 24/7 Wall St.'s breakdown of the filing. In plain English: Northrop signed $1.50 of new work for every $1.00 of revenue it booked.

Backlog hit a record $109.6 billion on a 1.5x book-to-bill ratio, meaning Northrop won $1.50 in new contract value for every dollar of revenue it recognized.

Growth was broad. Aeronautics sales climbed 14% on F-35 production timing, higher B-21 revenue and B-2 sustainment work. Defense Systems rose 12% as the Sentinel program ramped. Mission and space was the laggard at 2%.

Cash flow backed up the earnings. Operating cash flow grew 12% to $1.745 billion, and a lower tax rate of 13.4%, helped by research credits, did some of the lifting on the bottom line.

Now the caveats, because there are a few. Operating margin slipped to 11.4% from 11.9%, mostly because of a smaller pension-related accounting benefit. Net earnings rose just 2% to $1.124 billion, a lot slower than the headline EPS beat suggests.

The chart is still repairing. Even after the pop, NOC sits above its 50-day average near $524 but shy of its 200-day near $551. One good print doesn't erase a rough few months.

Analysts remain constructive but not unanimous. MarketBeat's tally has a consensus rating of Moderate Buy and an average target of about $642.

Rothschild & Co Redburn started coverage on October 6 with a Buy and a $680 target, while BNP Paribas Exane trimmed its target to $540 the same day and kept Outperform.

For investors, the setup looks like this. The thesis is visibility: a backlog this size, plus programs like Sentinel and the B-21, gives Northrop revenue it can plan around into 2027. The company's own management says it expects sales and earnings growth to continue next year.

The levels to watch are practical ones. Does the stock hold above the mid-$500s, and can it push toward that $551 200-day line? A move through it would say the market believes the story. A fade back toward $510 would say Tuesday was a one-day relief rally.

Also keep in mind that defense names trade on budgets and geopolitics as much as earnings. Reuters noted that RTX raised its outlook on the same day with its own record backlog, so the sector tailwind is real, but it also means NOC's good news was partly shared.

Bottom line: Northrop earned this rally with a bigger backlog and a bigger profit forecast, but the next leg depends on turning that order book into margin.